Neoadjuvant immunotherapy improves outlook in high-risk melanoma

Cancer. 2023 Jul 1;129(13):1952. doi: 10.1002/cncr.34884.
No abstract available

Publication types

  • News
  • Comment

MeSH terms

  • Humans
  • Immunotherapy
  • Melanoma* / therapy
  • Neoadjuvant Therapy
  • Skin Neoplasms* / drug therapy